TNIK inhibitor discovered and designed using Generative Al and Hallmarks of Aging Assessment for fibrosis (IMAGE)
Caption
For the first time, a new paper in Nature Biotechnology discloses the raw experimental data and the preclinical and clinical evaluation of Insilico Medicine's potentially first-in-class TNIK inhibitor discovered and designed using generative AI.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content